Crowdonomics
WatchlistPortfolio
All companies
ALLERPOPS logo

ALLERPOPS

Operating

AllerPops Corp

Healthcare · Founded 2016

Visit website

Liberate millions from allergies

Post-money valuation ⓘ
$9.9M
As of Aug 2023 · from Reg CF Offering (2023) · pre-money + amount raised, not a traded price
Total raised
$1,285,434
Crowd $420K · Private $866K · 5 rounds since 2020
Latest share price
$1.10
Reg CF · Preferred Stock · Jan 2023 offering price

Financials

FY2018–FY2021 · from SEC filings · hover any figure for its source
$21K
−$163K
2018
$21K
−$163K
2019
$41K
−$137K
2020
$58K
−$353K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018 reviewed*
FY2019 reviewed*
FY2020 reviewed
FY2021 reviewed
Income statement
Revenue
$20,549
$20,549
$40,802
$58,156
Cost of goods sold
$4,035
$4,035
$8,327
$16,394
Gross margin
80%
80%
80%
72%
Net income
-$163,330
-$163,330
-$136,665
-$353,340
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$4,916
$4,916
$64,089
$26,616
Accounts receivable
$0
$0
$150
$300
Total assets
$84,579
$84,579
$204,095
$181,458
Short-term debt
$4,496
$4,496
$17,342
$19,360
Long-term debt
$0
$0
$199,131
$291,962
Total liabilities
$4,496
$4,496
$216,473
$311,322
Other
Headcount
—
1
—
1

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$7.5M
pre-money
$9.8M
pre-money
Reg CF · Preferred · Mar 2021
Reg CF · Preferred · Jan 2023

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$1.10$0.55$0.89
Mar 2021Jan 2023
Round offering price or verified disclosed saleDisclosed sale, unverified or year-only

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Reg CF · Preferred Stock · Jan 2023Closedvia WeFunder
Raised $166.1K / $618KInvestors 193Post-money $9.9M
Section 4(a)(2) · Preferred Stock · Nov 2021Closed
Raised $760.5K
Rule 506(b) · Equity · Sep 2021Closed
Raised $50KInvestors 2
Reg CF · Preferred Stock · Mar 2021Closedvia WeFunder
Raised $253.5K / $500KInvestors 295Post-money $7.8M
Section 4(a)(2) · Jun 2020Closed
Raised $55.3K

Team

2 people
Cliff HanFounder
Founder and CEO
Amanda Giannini
CFO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 1 of 6 annual reports (FY2020–FY2025)

295 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AApr 24, 20230001670254-23-000385
    EDGAR
  • Form C-ARDec 16, 20220001670254-22-001263
    EDGAR
  • Form CDec 16, 20220001670254-22-001264
    EDGAR
  • Form DSep 28, 20210001839211-21-000001
    EDGAR
  • Form C/AFeb 9, 20210001670254-21-000124
    EDGAR
  • Form CJan 29, 20210001670254-21-000068
    EDGAR
Source: ManualCIK 0001839211Share price $1.10

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.